The Next 340B Pressure Point: Mixed-Use Pharmacy
The "assumed eligibility" era ended today; as of May 1, 2026, AstraZeneca, BMS, and ...
Deeper Expertise, Better Outcomes: Meet Our New Chief Pharmacy and Strategy Officer
The 340B landscape is shifting. Health systems are under more scrutiny, managing more ...
AI in 340B: Managing Today's Complexity with 2019 Effort
At the 340B Winter Conference 2026, PharmaForce Chief Product Officer Anthony Velasquez ...
The 340B Rebate Model: What Just Happened and What Comes Next
First, a Quick Primer: How the 340B Discount Has Always Worked